EXAS vs MAX · rev $2.76B vs P/E 36, rev $864.7M
EXACT Sciences Corporation (EXAS) versus MediaAlpha Inc. (MAX) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
MediaAlpha Inc. (MAX) is a internet content & information company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported MAX revenue for 2024-12-31 was $864.7M. Net income was $22.1M. Revenue was up 122.8% from 2023-12-31 to 2024-12-31. MAX currently screens at market cap $689.0M and trailing P/E 36.2.
EXAS currently screens at market cap $20.03B. MAX currently screens at market cap $689.0M and trailing P/E 36.2.
Not investment advice. Open the EXAS and MAX stock pages for the full models.
Not investment advice.